ClinicalTrials.gg
RecruitingNCT07556536Updated Apr 29, 2026

Comparison of Serratus Intercostal Plane Blcok With Erector Spinae Plane Block for Open Nephrectomy

An interventional study of Serratus Intercostal Plane Block and Erector Spinae Plane Block in Post Operative Pain and Open Nephrectomy, sponsored by Fayoum University Hospital. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Fayoum University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Pain, Postoperative by Fayoum University Hospital — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Fayoum University Hospital.

Planned enrollment
2nd of 17
132 · median 66
Started
2026
with 2 others
No phase
14 of 17
4 open now
Registered
17th of 17
by date

Among the 17 studies in Pain, Postoperative by Fayoum University Hospital, this one is the 2nd largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 17th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

4 of the 17 studies in Pain, Postoperative by Fayoum University Hospital are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Pain, Postoperative by Fayoum University Hospital, or all of them as a file.
02

Study summary

Effective postoperative pain management following open nephrectomy remains a significant clinical challenge.

Inadequate pain control after this procedure may lead to impaired respiratory function, delayed mobilization, prolonged hospital stay, increased opioid consumption, and a higher incidence of postoperative complications. Therefore, optimizing postoperative analgesia while minimizing opioid-related adverse effects is a key objective in perioperative care for patients undergoing open nephrectomy Traditionally, postoperative pain following open nephrectomy has been managed using systemic opioids, epidural analgesia, or paravertebral blocks.

Ultrasound-guided fascial plane blocks have emerged as valuable alternatives in modern regional anesthesia due to their simplicity, safety profile, and effectiveness. Among these techniques, the erector spinae plane (ESP) block has gained widespread popularity.

This block has been shown to provide effective analgesia for thoracic, abdominal, and urologic surgeries, including nephrectomy The ultrasound-guided serratus intercostal plane block (SIPB) is a more recently described regional anesthetic technique targeting the lateral cutaneous branches of the intercostal nerves by injecting local anesthetic between the serratus anterior muscle and the intercostal muscles or ribs By blocking these nerves, SIPB provides analgesia to the lateral thoracic wall and upper abdominal regions, which are particularly relevant to flank incisions used in open nephrectomy.

Patients will be randomly allocated into two equal groups. Patients in group (S) will receive serratus intercostal plane block and those in group (E) will receive Erector spinae plane block . Both of these blocks will be performed after induction of general anaesthesia by an experienced anaesthesiologist The aim of this study is to to compare the analgesic efficacy of ultrasound-guided serratus intercostal plane block and erector spinae plane block in patients undergoing open nephrectomy.

Read the detailed description

This double-blinded, prospective, randomized comparative study will be conducted in Fayoum University hospital after the approval of local Institutional Ethics Committee and local institutional review board. Written informed consent will be obtained from all patients for these scientific contributions before recruitment and randomization.

Patients will be randomly allocated into two equal groups using a computer-generated randomization sequence with a 1:1 allocation ratio. Group assignments will be concealed in sealed opaque envelopes opened immediately before block performance. The patients (as block will be given after induction of general anesthesia) and outcome assessors will be blinded to group allocation. The anesthesiologist performing the block will not participate in data collection or postoperative assessment.

All patients will receive standardized general anesthesia. Following induction of anesthesia and before surgical incision, the assigned regional block will be performed under ultrasound guidance using strict aseptic precautions.

Preoperative assessment Complete history taking, physical examination and investigation will be done according to hospital protocol to evaluate the patients, Which includes complete blood count, serum urea and creatinine, liver function tests, coagulation profile, electrocardiogram (ECG) and ECHO when clinically indicated and based on patient medical condition and perioperative risk assessment.

Before surgery, details of the nerve block procedures and the VAS pain score (0-10 cm) will be illustrated to the patients (where 0=no pain and 10 = worst pain imaginable).

An informed consent will be obtained from participants. Patients will fast for about 6 hours for solid meals, 4 hours for non-clear liquids and 2 hours for clear liquids before surgery Anesthetic technique

  • Intravenous access with a 18-gauge intravenous (IV) cannula will be inserted in the hand and standard monitoring (noninvasive blood pressure, electrocardiography, pulse oximetry and capnography ) will be applied.
  • All patients will receive pre-oxygenation with O2 100% for 3 min. Anesthesia will be induced by using fentanyl 1μg/kg, propofol 1.5-2 mg/kg and atracurium 0.5 mg/kg will be used for muscle relaxation. Anesthesia will be maintained by controlled ventilation with oxygen and air (50:50) with target of EtCo2≈ 35-40 mmHg, isoflurane 1 minimum alveolar concentration (MAC), 0.5μg/kg fentanyl will be given intraoperative when either heart rate or NIBP report an increase by more than 20% of the basal record. The standardized rescue protocol will be applied by independent anesthesiologist unaware of study hypothesis
  • At the end of the operation, Anesthesia will be discontinued and extubation will be done once patient fulfilled the extubation criteria.

Block techniques Patients in group (S) will receive serratus intercostal plane block and those in group (E) will receive Erector spinae plane block . Both of these blocks will be performed after induction of general anaesthesia by an experienced anaesthesiologist

Group (S) Serratus Intercostal Plane Block:

Block will be performed in the operating room, With the patient in the supine decubitus position, aseptic conditions were provided for the block, The high-frequency linear transducer of ultrasound (LOGIQ P7) will be placed in the mid-axillary line at the level of the eighths rib. The serratus anterior muscle and underlying intercostal muscles will be identified. A 22-gauge, 50 mm echogenic needle (Stimuplex D; B Braun, Germany) will be advanced in plane in the caudo-cranial direction. After negative aspiration, 25 mL of 0.25% bupivacaine HCl (plain)will be injected between the serratus anterior muscle and the intercostal muscles.

Group (E) Erector Spinae Plane Block:

Block will be performed in the operating room, With the patient in the lateral decubitus position, Aseptic conditions were provided for the block, The high-frequency linear transducer of ultrasound (LOGIQ P7) will be placed parasagittally at the level of the T8-T10 transverse process. The erector spinae muscle and transverse process will be identified. A 22-gauge, 50 mm echogenic needle (Stimuplex D; B Braun, Germany) will be advanced in plane in the cranio-caudal direction and after negative aspiration, 25 mL of 0.25% bupivacaine HCl (plain) will be injected deep to the erector spinae muscle.

Local Anesthetic Dose, Safety, and Emergency Preparedness

  1. Dose: 25 mL of 0.25% bupivacaine HCl (plain), equivalent to 62.5 mg. The maximum safe dose of plain bupivacaine will be strictly adhered to, defined as 2 mg/kg, not exceeding an absolute maximum of 150 mg.
  2. Slow Incremental Injection: The standard practice is to inject the local anesthetic under ultrasound guidance in small boluses, commonly 5-10 mL at a time, followed by aspiration to rule out intravascular placement and systemic toxicity.
  3. Emergency preparedness measures included:

    • Lipid rescue protocol availability: 20% Intralipid solution will be readily available for immediate intravenous administration in the event of local anesthetic systemic toxicity (LAST), according to ASRA guidelines.
    • Allergic/anaphylaxis management: Emergency medications (adrenaline, antihistamines, corticosteroids) and resuscitation equipment will be available, with a predefined protocol for prompt management of any hypersensitivity reactions.
    • Stop rule will be applied if unexpected adverse events (e.g., severe hypotension, arrhythmia, LA toxicity).

Block Success Assessment

After recovery from anesthesia (PACU):

Cold sensation test using alcohol swab at T7-T12 dermatomes. Block considered successful if ≥3 dermatomes sensory loss within 30 min. Failed blocks will be recorded and analyzed

Postoperative Analgesia

  • Routine Analgesia: Paracetamol (1 g every 6 hours) will be administered intravenously as a baseline routine analgesic.
  • Rescue analgesia will be administered via intravenous morphine using a PCA pump programmed to deliver 1 mg per demand with a 10-minute lockout interval and no basal infusion. Cumulative 24-hour morphine consumption will be recorded.

Sample size calculation The sample size was calculated using G*Power software (version 3.1.9.7) based on the primary outcome measure: VAS pain score at rest and during deep inspiration at 12 hours postoperatively. Based on data from Fernandez Martin et al. (2025), who compared SIPB with posterior quadratus lumborum block in laparoscopic nephrectomy and reported a mean NRS score of 2.35 (±1.92) in the SIPB group at 12 hours, and from Wadood et al. (2024), who reported a median NRS score of 3.0 in the ESPB group at 12 hours in open nephrectomy. the investigators estimated the mean and standard deviation in the ESPB group to be 3.24 (±1.47) based on Luo et al. (2018) and Wan et al. (2014).

Using a two-sided independent samples t-test with a type I error (α) of 0.05 and a statistical power (1-β) of 80%, a minimum of 59 patients per group was calculated to be required. Accounting for an anticipated dropout rate of approximately 10%, the total sample size was increased to 66 patients per group, yielding a final target enrollment of 132 patients in total. The calculation was based on the following parameters: effect size d = 0.524, α = 0.05 (two-tailed), power = 0.80, and equal allocation ratio (1:1).

Statistical Analysis Data will be collected and analyzed using IBM SPSS Statistics for Windows, Version 26.0 (IBM Corp., Armonk, NY, USA). Continuous variables will be expressed as mean ± standard deviation (SD) or median with interquartile range (IQR), depending on the normality of data distribution. Categorical variables will be presented as frequencies and percentages. Normality of distribution will be assessed using the Shapiro-Wilk test.

For normally distributed continuous data, comparisons between the two groups will be performed using the independent samples Student's t-test. For non-normally distributed continuous data, the Mann-Whitney U test will be used. Categorical variables will be compared using the Chi-square test or Fisher's exact test, as appropriate. Repeated measurements over time (e.g., VAS scores at multiple postoperative time points) will be analyzed using a repeated-measures analysis of variance (ANOVA) or the Friedman test for non-parametric data, with appropriate post-hoc corrections (Bonferroni) for multiple comparisons.

The primary outcome (VAS score at rest at 12 hours postoperatively) will be the main variable for inferential testing. Time to first rescue analgesia will be analyzed using Kaplan-Meier survival analysis and compared between groups using the log-rank test. All tests will be two-tailed.

Effect size with 95% CI reported A p-value of less than 0.05 will be considered statistically significant.

03

Conditions studied

  • Post Operative Pain
  • Open Nephrectomy

Browse trials for

Keywords

  • serratus intercostal plane block
  • Erector spinae plane block
  • open nephrectomy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients scheduled for elective open nephrectomy under general anesthesia via flank incision .
  2. Adult patients aged 18-65 years.
  3. Patients with an (ASA) physical status I to III.

Exclusion criteria

Exclusion Criteria:

  1. Patient refusal.
  2. Allergy to local anesthetics and patient with infection at the injection site of block.
  3. Coagulation disorders or ongoing anticoagulant therapy.
  4. Patients receiving opioids for chronic analgesic therapy (cancer, addiction).
  5. Cognitive impairment preventing pain scoring.
  6. Neurological or psychiatric disorders affecting pain assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Group (S) Serratus Intercostal Plane Block:

    Patients in group (S) will receive ultrasound-guided serratus intercostal plane after induction of general anaesthesia by an experienced anaesthesiologist

    Procedure: Serratus Intercostal Plane Block

  • Experimental
    Group (E) Erector Spinae Plane Block:

    Patients in group (E) will receive ultrasound-guided Erector spinae plane block after induction of general anaesthesia by an experienced anaesthesiologist

    Procedure: Erector Spinae Plane Block

Interventions

  • ProcedureSerratus Intercostal Plane Block

    Block will be performed in the operating room, With the patient in the supine decubitus position, aseptic conditions were provided for the block, The high-frequency linear transducer of ultrasound (LOGIQ P7) will be placed in the mid-axillary line at the level of the eighths rib. The serratus anterior muscle and underlying intercostal muscles will be identified. A 22-gauge, 50 mm echogenic needle (Stimuplex D; B Braun, Germany) will be advanced in plane in the caudo-cranial direction. After negative aspiration, 25 mL of 0.25% bupivacaine HCl (plain)will be injected between the serratus anterior muscle and the intercostal muscles.

  • ProcedureErector Spinae Plane Block

    Block will be performed in the operating room, With the patient in the lateral decubitus position, Aseptic conditions were provided for the block, The high-frequency linear transducer of ultrasound (LOGIQ P7) will be placed parasagittally at the level of the T8-T10 transverse process. The erector spinae muscle and transverse process will be identified. A 22-gauge, 50 mm echogenic needle (Stimuplex D; B Braun, Germany) will be advanced in plane in the cranio-caudal direction and after negative aspiration, 25 mL of 0.25% bupivacaine HCl (plain) will be injected deep to the erector spinae muscle.

06

What researchers measure

Primary outcomes

  1. • Postoperative pain score at rest 12 hours after surgery measured using the 0-10 Visual Analogue Scale (VAS).

    VAS pain score (0-10 cm) (where 0=no pain and 10 = worst pain imaginable).

    Time frame: 12 hours post-surgery

Secondary outcomes

  1. • Postoperative pain intensity assessed using the VAS at rest and during deep inspiration at the immediate postoperative period, 2, and 6 hours postoperatively.

    VAS pain score (0-10 cm) (where 0=no pain and 10 = worst pain imaginable).

    Time frame: 0, 2, and 6 hours after surgery completion

  2. • Postoperative pain intensity assessed using the visual analogue scale (VAS) during deep inspiration at 12 hours postoperatively

    VAS pain score (0-10 cm) (where 0=no pain and 10 = worst pain imaginable). during deep expiration

    Time frame: 12 hours post-surgery

  3. • Block success rate (dermatomal sensory loss)

    After recovery from anesthesia (PACU): Cold sensation test using alcohol swab at T7-T12 dermatomes. Block considered successful if ≥3 dermatomes sensory loss within 30 min. Failed blocks will be recorded and analyzed

    Time frame: 30 minutes After arrival in Post-Anaesthesia Care Unit (PACU)

  4. • Cumulative morphine consumption in 24 hours (in mg).

    • Rescue analgesia will be administered via intravenous morphine using a PCA pump programmed to deliver 1 mg per demand with a 10-minute lockout interval and no basal infusion. Cumulative 24-hour morphine consumption will be recorded

    Time frame: From surgery completion up to 24 hours post-surgery

  5. • Time to first request for rescue analgesia (in hours).

    • Rescue analgesia will be administered via intravenous morphine using a PCA pump programmed to deliver 1 mg per demand with a 10-minute lockout interval and no basal infusion.

    Time frame: From surgery completion up to 24 hours post-surgery

  6. • Incidence of opioid-related side effects

    including nausea, vomiting, pruritus, and respiratory depression.

    Time frame: From surgery completion up to 24 hours post-surgery

  7. • Incidence of block-related adverse events

    such as vascular puncture or local anesthetic toxicity.

    Time frame: From start of nerve block until end of surgery

  8. • Length of stay in the hospital.

    post operative hospital stay

    Time frame: from date of surgery completion until the the date of hospital discharge, assessed up yo 30 days

  9. Intraoperative opioid consumption.

    fentanyl will be given intraoperative when either heart rate or NIBP report an increase by more than 20% of the basal record.

    Time frame: from start of surgery up to surgery completion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Alsmadi JK, Nofal MN, Alriyalat S, Yousef AJ. Laparoscopic vs. Open nephrectomy for inflammatory renal conditions: a meta-analysis emphasizing safety. BMC Urol. 2025 Apr 21;25(1):96. doi: 10.1186/s12894-025-01781-z. PubMed 40254599 ↗
  • Koksal BG, Baytar C, Bayraktar E, Balbaloglu H. Effects of serratus posterior superior intercostal plane block on postoperative analgesia in patients undergoing breast cancer surgery: a randomized controlled trial. BMC Anesthesiol. 2025 Apr 24;25(1):209. doi: 10.1186/s12871-025-03092-0. PubMed 40275145 ↗
  • Wang J, Deng Y, Chen Q, Chen F, Li H. Acute postoperative pain management after cardiothoracic surgery: a bibliometric analysis and future directions. J Cardiothorac Surg. 2025 Nov 27;20(1):477. doi: 10.1186/s13019-025-03734-x. PubMed 41310790 ↗
  • Mamoun MA, Alrefaey AK, Abo-Zeid MA. Continuous Serratus - Intercostal Plane Block for Perioperative Analgesia in Upper Abdominal Surgeries: A Prospective Randomized Controlled Study. Turk J Anaesthesiol Reanim. 2023 Oct 24;51(5):402-407. doi: 10.4274/TJAR.2023.231260. PubMed 37876166 ↗
  • Liu QR, Dai YC, Ji MH, Liu PM, Dong YY, Yang JJ. Risk Factors for Acute Postsurgical Pain: A Narrative Review. J Pain Res. 2024 May 20;17:1793-1804. doi: 10.2147/JPR.S462112. eCollection 2024. PubMed 38799277 ↗
  • Lee J, Kim S. The effects of ultrasound-guided serratus plane block, in combination with general anesthesia, on intraoperative opioid consumption, emergence time, and hemodynamic stability during video-assisted thoracoscopic lobectomy: A randomized prospective study. Medicine (Baltimore). 2019 May;98(18):e15385. doi: 10.1097/MD.0000000000015385. PubMed 31045789 ↗
  • Song WQ, Wang W, Yang YC, Sun Q, Chen H, Zhang L, Bu XS, Zhan LY, Xia ZY. Parasternal Intercostal Block Complementation Contributes to Postoperative Pain Relief in Modified Radical Mastectomy Employing Pectoral Nerve Block I and Serratus-Intercostal Block: A Randomized Trial. J Pain Res. 2020 Apr 30;13:865-871. doi: 10.2147/JPR.S237435. eCollection 2020. PubMed 32431534 ↗
  • Yang X, Zhang Y, Chen Y, Xu M, Lei X, Fu Q. Analgesic effect of erector spinae plane block in adults undergoing laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiol. 2023 Jan 6;23(1):7. doi: 10.1186/s12871-023-01969-6. PubMed 36609244 ↗
  • Alper I, Yuksel E. Comparison of Acute and Chronic Pain after Open Nephrectomy versus Laparoscopic Nephrectomy: A Prospective Clinical Trial. Medicine (Baltimore). 2016 Apr;95(16):e3433. doi: 10.1097/MD.0000000000003433. PubMed 27100439 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 10 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 10 months is close to that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2026
First posted
Apr 29, 2026
StartActual
Apr 10, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Apr 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07556536
Lead sponsor
Fayoum University Hospital
Responsible party
Mohamed Ahmed Hamed (Professor of Anesthesia, Surgical ICUS &Pain Management, Fayoum University Hospital) — Principal investigator
First posted
Apr 29, 2026
Start date
Apr 10, 2026
Primary completion
Mar 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Apr 29, 2026

Study contacts

Hasnaa M Hashem, Master
Contact
hm163@fayoum.edu.eg
01064437956
Amr H Mahmoud, MD
Contact
amrhamdy69@yahoo.com
01004349592
Mohamed A Hamed, MD
principal investigator · faculty of medicine, fayoum university

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion